
Sign up to save your podcasts
Or


What are you waiting for? Learn about tools for screening and diagnosis of bipolar depression. Credit available for this activity expires: 09/27/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/981404?src=mkm_podcast_addon_981404
Did you know that quality of life for patients with skin of color with psoriasis is significantly worse than quality of life reported for white patients?
Credit available for this activity expires: 9/26/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/981333?src=mkm_podcast_addon_981333
Can you recognize and manage disease in heavily treatment-experienced (HTE) people with HIV (PWH) in a primary care practice?
Credit available for this activity expires: 9/12/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/980534?src=mkm_podcast_addon_980534
Can you identify insomnia in your patients? Learn more about appropriate assessment scales.
Credit available for this activity expires: 9/1/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/978057?src=mkm_podcast_addon_978057
Are you up to date on the interprofessional management of CLL?
Credit available for this activity expires: 08/26/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979760?src=mkm_podcast_addon_979760
Can you identify the 3 protocol types used for abbreviated liver magnetic resonance imaging (MRI)?
Credit available for this activity expires: 8/29/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/978640?src=mkm_podcast_addon_978640
Do you know how PARP inhibitors exploit synthetic lethality to treat cancer?
Credit available for this activity expires: 8/26/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979714?src=mkm_podcast_addon_979714
Did you know that noncovalent Bruton tyrosine kinase (BTK) inhibitors are a potential solution to overcome the challenge of covalent BTK inhibitor resistance in chronic lymphoblastic leukemia (CLL)?
Credit available for this activity expires: 8/24/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979645?src=mkm_podcast_addon_979645
From the publisher's feed

136 Listeners

697 Listeners

499 Listeners

163 Listeners

103 Listeners

893 Listeners

13 Listeners

16 Listeners

291 Listeners

264 Listeners

3,347 Listeners

1,158 Listeners

195 Listeners

93 Listeners

520 Listeners

371 Listeners

171 Listeners

60 Listeners

8 Listeners

430 Listeners